CN118891269A - 核酸寡聚物的制造方法 - Google Patents

核酸寡聚物的制造方法 Download PDF

Info

Publication number
CN118891269A
CN118891269A CN202380028404.9A CN202380028404A CN118891269A CN 118891269 A CN118891269 A CN 118891269A CN 202380028404 A CN202380028404 A CN 202380028404A CN 118891269 A CN118891269 A CN 118891269A
Authority
CN
China
Prior art keywords
group
formula
mol
production method
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380028404.9A
Other languages
English (en)
Chinese (zh)
Inventor
宫川卓也
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of CN118891269A publication Critical patent/CN118891269A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN202380028404.9A 2022-03-23 2023-03-20 核酸寡聚物的制造方法 Pending CN118891269A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022-047341 2022-03-23
JP2022047341 2022-03-23
PCT/JP2023/010891 WO2023182274A1 (ja) 2022-03-23 2023-03-20 核酸オリゴマーの製造方法

Publications (1)

Publication Number Publication Date
CN118891269A true CN118891269A (zh) 2024-11-01

Family

ID=88100953

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380028404.9A Pending CN118891269A (zh) 2022-03-23 2023-03-20 核酸寡聚物的制造方法

Country Status (6)

Country Link
US (1) US12509485B2 (https=)
EP (1) EP4488282A4 (https=)
JP (1) JPWO2023182274A1 (https=)
KR (1) KR20240162536A (https=)
CN (1) CN118891269A (https=)
WO (1) WO2023182274A1 (https=)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077709A (en) 1998-09-29 2000-06-20 Isis Pharmaceuticals Inc. Antisense modulation of Survivin expression
DK1149109T3 (da) 1999-02-05 2010-01-11 Ge Healthcare Bio Sciences Fremgangsmåde til afbeskyttelse af oligonukleotider
US6261840B1 (en) 2000-01-18 2001-07-17 Isis Pharmaceuticals, Inc. Antisense modulation of PTP1B expression
ES2386709T3 (es) 2004-08-26 2012-08-27 Nippon Shinyaku Co., Ltd. Compuesto de fosforamidita y método para producir un oligo-ARN
US8158775B2 (en) * 2006-02-27 2012-04-17 Nippon Shinyaku Co., Ltd. Method for detaching protecting group on nucleic acid
WO2008049085A1 (en) 2006-10-18 2008-04-24 Isis Pharmaceuticals, Inc. Antisense compounds
HUE037500T2 (hu) 2010-07-08 2018-08-28 Bonac Corp Egyszálú nukleinsav molekula a génexpresszió szabályozására
ES2527660T3 (es) 2010-08-03 2015-01-28 Bonac Corporation Molécula de ARN monocatenario que tiene esqueleto alicíclico que contiene nitrógeno
WO2013027843A1 (ja) 2011-08-25 2013-02-28 株式会社ボナック 配糖体化合物、チオエーテルの製造方法、エーテル、エーテルの製造方法、配糖体化合物の製造方法、核酸の製造方法
US9528111B2 (en) 2012-01-07 2016-12-27 Bonac Corporation Single-stranded nucleic acid molecule having amino acid backbone
EP3241902B1 (en) 2012-05-25 2018-02-28 The Regents of The University of California Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US10900034B2 (en) 2014-12-03 2021-01-26 Agilent Technologies, Inc. Guide RNA with chemical modifications
JP6787398B2 (ja) 2016-04-26 2020-11-18 住友化学株式会社 一本鎖核酸分子用モノマーの製造方法
EP3604528A4 (en) 2017-03-31 2021-01-13 Bonac Corporation CYCLIC NUCLEIC ACID MOLECULE WITH GENE EXPRESSION CONTROL FUNCTION
KR20250046363A (ko) 2017-09-19 2025-04-02 알닐람 파마슈티칼스 인코포레이티드 트랜스타이레틴(ttr) 매개 아밀로이드증을 치료하기 위한 조성물 및 방법
US20210188895A1 (en) 2017-10-13 2021-06-24 Bonac Corporation Single-stranded nucleic acid molecule, and production method therefor
TWI830718B (zh) * 2018-02-09 2024-02-01 日商住友化學股份有限公司 核酸分子之製造方法
US20230192755A1 (en) * 2020-04-14 2023-06-22 Sumitomo Chemical Company, Limited Composition containing nucleic acid oligomer
US20230242570A1 (en) * 2020-07-09 2023-08-03 Sumitomo Chemical Company, Limited Method for producing nucleic acid oligomer
JP7570858B2 (ja) 2020-09-11 2024-10-22 日鉄ステンレス株式会社 マルテンサイト系ステンレス鋼板およびマルテンサイト系ステンレス鋼板の製造方法
JP7719788B2 (ja) * 2020-09-24 2025-08-06 住友化学株式会社 核酸オリゴマーの製造方法

Also Published As

Publication number Publication date
WO2023182274A1 (ja) 2023-09-28
US20250145655A1 (en) 2025-05-08
KR20240162536A (ko) 2024-11-15
EP4488282A4 (en) 2025-11-19
US12509485B2 (en) 2025-12-30
JPWO2023182274A1 (https=) 2023-09-28
EP4488282A1 (en) 2025-01-08

Similar Documents

Publication Publication Date Title
DK2857412T3 (en) Method for Oligonucleotide Synthesis Using High-Resolution Liquid Phase Carrier
JP7640461B2 (ja) 核酸オリゴマーの製造方法
JP6730932B2 (ja) リン保護基ならびにそれらの調製方法および使用
WO1998039352A1 (en) Novel bicyclonucleoside and oligonucleotide analogues
EA003091B1 (ru) Синтез олигонуклеотидов в жидкой фазе
JP7719788B2 (ja) 核酸オリゴマーの製造方法
AU2013234303A1 (en) Tricyclic nucleosides and oligomeric compounds prepared therefrom
CZ20022930A3 (cs) Způsob výroby fosfonothioátových triesterů
WO2021153047A1 (ja) 核酸オリゴマーの製造方法
CN118891269A (zh) 核酸寡聚物的制造方法
WO2022009959A1 (ja) 核酸オリゴマーの製造方法
EP4563559A1 (en) Thionizing solution
CA2659703C (en) Method for introducing a nucleic-acid-protecting group
CN117980285A (zh) 纯化二氯乙酸的制造方法
WO2024019137A1 (ja) オリゴヌクレオチドの製造方法
JP7825064B2 (ja) オリゴヌクレオチドの製造方法
JP7776154B2 (ja) ホスホロチオエート及びボラノホスフェートを含むキメラ型核酸オリゴマー、及びその製造方法
CN120418262A (zh) 寡核苷酸的制造方法
CN121464145A (zh) 寡核苷酸合成用的高脂溶性核苷酸砌块及使用其的寡核苷酸的合成
CN115315430A (zh) 使用了链段型亚磷酰胺化合物的核酸合成法
AU2005315631A1 (en) Synthesis of phosphitylated compounds using a quaternary heterocyclic activator

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination